CardioTech Reports Clinical Trial Is Underway For CardioPass(TM) After Receipt Of FDA Export License For Synthetic Coronary Bypass Graft

... CardioTech International, Inc. (Amex: CTE), a developer and manufacturer of advanced medical device materials and products for the treatment of cardiovascular and other diseases, today reported that its European clinical trial of CardioPass(TM), the Company's proprietary synthetic coronary bypass graft, is now underway. [click link for full article] ...